| CASE REPORT |
|
| Year : 2021 | Volume
: 15
| Issue : 1 | Page : 36-38 |
|
|
Chronic pulmonary thromboembolism in a patient of erythema nodosum leprosum treated with thalidomide and corticosteroid
Sangam Singh, Mahim Mittal, Minakshi Awasthi, Neeraj Chaudhary
Department of Medicine, BRD Medical College, Gorakhpur, Uttar Pradesh, India
Correspondence Address:
Dr. Sangam Singh
SR BRD Medical College, Gorakhpur, Uttar Pradesh
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/upjimi.upjimi_5_21
|
|
|
Thalidomide is the drug of choice for erythema nodosum leprosum (ENL) in men. Its use in patients with multiple myeloma has been reported to cause venous thrombosis. Postulated mechanism is an increase in procoagulant state with the use of thalidomide along with corticosteroids in the underlying hyperviscosity in multiple myeloma. We report a case of superficial and deep vein thrombosis and chronic pulmonary vein embolism in a patient of ENL treated with thalidomide and corticosteroid. An increase in procoagulant state with the use of these two medicines along with a persistent inflammatory state in ENL and an increased risk of venous thrombosis in type 3 hypersensitivity together may have resulted in thrombus formation.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
